BCRXBioCryst Pharmaceuticals, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+14% of shares).
Choppy, but holding above its 200-day average. Price is +0% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BCRX is trading
BioCryst Pharmaceuticals, Inc. is +11% over the past year while the S&P 500 is +18%: 7.2 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +0.11%
vs 200-day average · close to trend
- RSI (14)
- 45
RSI (14) · neutral
- Below its 52-week high
- 19%
Below its 52-week high
Details›
- Last close2026-10-09
- $8.56
- 1 monthS&P 500 +2.7%
- +3.1%
- 1 yearS&P 500 +18%
- +11%
- 5 yearsS&P 500 +88%
- −45%
- vs 50-day average$9.11
- −6.1%
- 52-week high
- $10.59
- 52-week low
- $6.24
- Annualised volatility
- 50%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$100K
| Year | Return |
|---|---|
| 2026 (year to date) | +9.7% |
| 2025 | +3.7% |
| 2024 | +26% |
| 2023 | −48% |
| 2022 | −17% |
| 2021 | +86% |
| 2020 | +116% |
| 2019 | −57% |
| 2018 | +64% |
| 2017 | −22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −2.3% |
| Feb | 10 | 7 of 10 | +7.6% |
| Mar | 10 | 2 of 10 | −3.2% |
| Apr | 10 | 4 of 10 | +2.4% |
| May | 10 | 7 of 10 | +9.4% |
| Jun | 10 | 6 of 10 | +0.03% |
| Jul | 11 | 6 of 11 | +0.87% |
| Aug | 11 | 6 of 11 | +6.6% |
| Sep | 11 | 3 of 11 | −5.4% |
| Oct | 11 | 5 of 11 | −4.9% |
| Nov | 10 | 7 of 10 | +13% |
| Dec | 10 | 7 of 10 | +7.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #41 of 41 by RyuScore